Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRuanne V. Barnabas, Kathleen M. Neuzil, Miriam K. Laufer et al.|Annals of Internal Medicine|2020Cited by 93
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and SeverityHelen C. Stankiewicz Karita, Elizabeth R. Brown, Tracy Qi Dong et al.|JAMA Network Open|2022Cited by 92
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|Nature Medicine|2023Cited by 56
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|medRxiv|2022Cited by 30